CONTACTMedia:

CONTACT InvestorRelations: Brussels London Paris +32.2.509.1392 +44.20.7379.2789 +33.1.49.27.11.33 NewYork +1.212.656.5700

nyx.com Pleasefollowusat: ExchangesBlog Facebook LinkedIn Twitter

Amsterdam Lisbon NewYork

+31.20.550.4488 +351.217.900.029 +1.212.656.2411

NYSEEuronextAnnouncesTradingVolumesforJanuary2013 GlobalDerivativesADVUp27%YoYDrivenbyStrongFixedIncomeTrading,Up64% U.S.EquityOptionsADVUp10%YoY;RecordMarketShareof29% U.S.andEuropeanCashADVDeclinedYoYButReboundedfromDecember2012levels February11,2013NYSEEuronext(NYX)todayannouncedtradingvolumesforitsglobal derivativesandcashequitiesexchangesforJanuary20131.Globalderivativesaveragedaily volume(ADV)of9.5millioncontractsinJanuary2013increased26.9%comparedto January2012,andincreased27.5%fromDecember2012drivenprincipallybystrongerfixed incomederivativesADVwhichincreased64%yearoveryearand91%monthovermonth. U.S.EquityoptionsvolumesreboundedinJanuary2013withanincreaseof9.9%comparedto January2012andanincreasedof17.9%fromDecember2012levels.U.S.Equityoptions combinedmarketsharesetanewrecordhighof29.4%inJanuary2013.Tradingvolumesin EuropeanandU.S.cashequitiesdeclinedyearoveryear,butimprovedfromDecember2012 levels. Highlights NYSEEuronextglobalderivativesADVinJanuary2013of9.5millioncontracts increased26.9%comparedtoJanuary2012andincreased27.5%fromDecember2012 levels. NYSEEuronextEuropeanderivativesproductsADVinJanuary2013of4.9million contractsincreased51.0%comparedtoJanuary2012,andincreased39.4%from December2012levels.ExcludingBclear,NYSELiffe'stradeadministrationandclearing serviceforOTCproducts,EuropeanderivativesproductsADVincreased43.5% comparedtoJanuary2012andincreased60.8%fromDecember2012. NYSEEuronextU.S.equityoptions(NYSEArcaandNYSEAmex)ADVof4.6million contractsinJanuary2013increased9.9%comparedtoJanuary2012levelsand increasedby17.9%fromDecember2012levels.NYSEEuronextsU.S.options exchangesaccountedfor29.4%oftotalU.S.consolidatedequityoptionstradingin January2013,settinganewrecordhigh.

AllNYSEEuronextderivativestransactionscountbuyandsellorderstogetherasasingletransaction.NYSEEuronext Europeanequitiestransactionscounteachbuyandsellorderasseparatetransactions,NYSEEuronextU.S.equities transactionscountbuyandsellorderstogetherasasingletransaction.

NYSEEuronextEuropeancashproductsADVof1.3milliontransactionsinJanuary 2013decreased14.4%comparedtoJanuary2012butincreased21.0%comparedto December2012. NYSEEuronextU.S.cashproducts(NYSE,NYSEArcaandNYSEMKT)handledADVof 1.6billionsharesinJanuary2012decreased14.4%comparedtoJanuary2012but increased1.5%comparedtoDecember2012.NYSEEuronextsTapeAmatched marketshareinJanuary2013was29.7%,downfrom30.3%inJanuary2012anddown from31.9%inDecember2012.

DerivativesTrading EuropeanDerivatives NYSEEuronextEuropeanderivativesproductsADVinJanuary2013was4.9million futuresandoptionscontracts,anincreaseof51.0%fromJanuary2012andan increaseof39.4%fromDecember2012. The4.9millioninEuropeanderivativesfuturesandoptionscontractsADVin November2012consistedof3.8millioncontractsexecutedthroughourfullservice LIFFECONNECTtradingplatformand1.0millioncontracts,or21.1%,executedthrough Bclear,NYSELiffe'stradeadministrationandclearingserviceforOTCproducts. ExcludingBclear,EuropeanderivativesproductsADVincreased43.5%comparedto January2012andincreased60.8%fromDecember2012. TotalfixedincomeproductsADVof3.0millioncontractsinJanuary2013increased 64.3%fromJanuary2012andincreased90.8%fromDecember2012. Totalequityproducts(includingBclear)ADVof1.8millioncontractsinJanuary2013 increased34.2%comparedtoJanuary2012butdecreased3.1%fromDecember2012. The1.8millioncontractsinequityproductsADVconsistedof1.3millioncontractsin individualequityproductsADVand0.5millioncontractsinequityindexproductsADV. The1.3millioncontractsinindividualequityproductsADVconsistedof0.8millionin futurescontracts,whichrepresenteda97.2%increasecomparedtoJanuary2012and 0.5millioninoptionscontracts,whichrepresenteda6.1%decreasecomparedto January2012. TotalcommoditiesproductsADVof89,000contractsinJanuary2013increased18.5% comparedtoJanuary2012,butdecreased8.4%comparedtoDecember2012. U.S.Derivatives NYSEEuronextU.S.equityoptions(NYSEArcaandNYSEAmex)ADVof4.6million contractsinJanuary2012increased9.9%comparedtoJanuary2012andincreased 17.9%comparedtoDecember2012. TotalU.S.consolidatedequityoptionsADVdecreased0.5%to15.6millioncontractsin January2013comparedtoJanuary2012,butincreased9.2%comparedtoDecember 2012. NYSEEuronextsU.S.optionsexchangesaccountedfor29.4%ofthetotalU.S. consolidatedequityoptionstradinginJanuary2013anewrecordhigh,upfrom26.6% inJanuary2012andupfrom27.2%inDecember2012.NYSEEuronextwasthe#1 optionsexchangegroupintermsofmarketshareinJanuary. NYSELiffeU.S.ADVofapproximately50,900contractsdecreasedfrom94,900 contractsinJanuary2012anddecreasedfrom72,600contractsinDecember2012. CashTrading

EuropeanCash NYSEEuronextEuropeancashproductsADVof1.3milliontransactionsinJanuary 2013decreased14.4%comparedtoJanuary2012,butincreased21.0%comparedto December2012. U.S.Cash NYSEEuronextU.S.cashproductshandledADVinJanuary2013decreased14.4%to 1.6billionsharescomparedtoJanuary2012butincreased1.5%fromDecember2012. NYSEEuronextsTapeAmatchedmarketshareinJanuary2013was29.7%,downfrom 30.3%inJanuary2012,anddownfrom31.9%inDecember2012. ExchangeTradedProducts NYSEEuronextU.S.matchedexchangetradedproductsADV(includedinvolumesfor TapeBandTapeC)of191millionsharesinJanuary2012decreased16.4%compared toJanuary2012anddecreased1.3%comparedtoDecember2012. PleaseclickherefortheMonthlyTransactionActivityDataTable.

AboutNYSEEuronext NYSEEuronext(NYX)isaleadingglobaloperatoroffinancialmarketsandproviderofinnovative tradingtechnologies.Thecompany'sexchangesinEuropeandtheUnitedStatestradeequities, futures,options,fixedincomeandexchangetradedproducts.Withapproximately8,000listedissues (excludingEuropeanStructuredProducts),NYSEEuronext'sequitiesmarketstheNewYorkStock Exchange,NYSEEuronext,NYSEMKT,NYSEAlternextandNYSEArcarepresentonethirdofthe worldsequitiestrading,themostliquidityofanyglobalexchangegroup.NYSEEuronextalsooperates NYSELiffe,oneoftheleadingEuropeanderivativesbusinessesandtheworld'ssecondlargest derivativesbusinessbyvalueoftrading.Thecompanyofferscomprehensivecommercialtechnology, connectivityandmarketdataproductsandservicesthroughNYSETechnologies.NYSEEuronextisin theS&P500index.Formoreinformation,pleasevisit:http://www.nyx.com. CAUTIONARYSTATEMENTREGARDINGFORWARDLOOKINGSTATEMENTS Thiscommunicationcontainsforwardlookingstatementsmadepursuanttothesafeharbor provisionsofthePrivateSecuritiesLitigationReformActof1995.Insomecases,youcanidentify forwardlookingstatementsbywordssuchasmay,hope,will,should,expect,plan, anticipate,intend,believe,estimate,predict,potential,continue,could,futureor thenegativeofthosetermsorotherwordsofsimilarmeaning.Youshouldcarefullyreadforward lookingstatements,includingstatementsthatcontainthesewords,becausetheydiscussourfuture expectationsorstateotherforwardlookinginformation.Forwardlookingstatementsaresubjectto numerousassumptions,risksanduncertaintieswhichchangeovertime.ICEandNYSEEuronext cautionreadersthatanyforwardlookingstatementisnotaguaranteeoffutureperformanceandthat actualresultscoulddiffermateriallyfromthosecontainedintheforwardlookingstatement. Forwardlookingstatementsinclude,butarenotlimitedto,statementsaboutthebenefitsofthe proposedmergerinvolvingICEandNYSEEuronext,includingfuturefinancialresults,ICEsandNYSE Euronextsplans,objectives,expectationsandintentions,theexpectedtimingofcompletionofthe transactionandotherstatementsthatarenothistoricalfacts.Importantfactorsthatcouldcause actualresultstodiffermateriallyfromthoseindicatedbysuchforwardlookingstatementsareset forthinICEsandNYSEEuronextsfilingswiththeU.S.SecuritiesandExchangeCommission(the SEC).Theserisksanduncertaintiesinclude,withoutlimitation,thefollowing:theinabilitytoclose

themergerinatimelymanner;theinabilitytocompletethemergerduetothefailureofNYSE EuronextstockholderstoadoptthemergeragreementorthefailureofICEstockholderstoapprove theissuanceofICEcommonstockinconnectionwiththemerger;thefailuretosatisfyother conditionstocompletionofthemerger,includingreceiptofrequiredregulatoryandotherapprovals; thefailureoftheproposedtransactiontocloseforanyotherreason;thepossibilitythatanyofthe anticipatedbenefitsoftheproposedtransactionwillnotberealized;theriskthatintegrationofNYSE EuronextsoperationswiththoseofICEwillbemateriallydelayedorwillbemorecostlyordifficult thanexpected;thechallengesofintegratingandretainingkeyemployees;theeffectofthe announcementofthetransactiononICEs,NYSEEuronextsorthecombinedcompanysrespective businessrelationships,operatingresultsandbusinessgenerally;thepossibilitythattheanticipated synergiesandcostsavingsofthemergerwillnotberealized,orwillnotberealizedwithinthe expectedtimeperiod;thepossibilitythatthemergermaybemoreexpensivetocompletethan anticipated,includingasaresultofunexpectedfactorsorevents;diversionofmanagements attentionfromongoingbusinessoperationsandopportunities;generalcompetitive,economic, politicalandmarketconditionsandfluctuations;actionstakenorconditionsimposedbytheUnited Statesandforeigngovernmentsorregulatoryauthorities;andadverseoutcomesofpendingor threatenedlitigationorgovernmentinvestigations.Inaddition,youshouldcarefullyconsidertherisks anduncertaintiesandotherfactorsthatmayaffectfutureresultsofthecombinedcompany,aswillbe describedinthesectionentitledRiskFactorsinthejointproxystatement/prospectustobe deliveredtoICEsandNYSEEuronextsrespectiveshareholders,andasdescribedinICEsandNYSE EuronextsrespectivefilingswiththeSECthatareavailableontheSECswebsitelocatedat www.sec.gov,includingthesectionsentitledRiskFactorsinICEsForm10Kforthefiscalyearended December31,2011,asfiledwiththeSEConFebruary8,2012,andICEsQuarterlyReportsonForm 10QforthequartersendedJune30,2012,asfiledwiththeSEConAugust1,2012,and September30,2012,asfiledwiththeSEConNovember5,2012,andRiskFactorsinNYSEEuronexts Form10KforthefiscalyearendedDecember31,2011,asfiledwiththeSEConFebruary29,2012, andNYSEEuronextsQuarterlyReportsonForm10QforthequartersendedMarch31,2012,asfiled withtheSEConMay4,2012,andSeptember30,2012,asfiledwiththeSEConNovember8,2012. Youshouldnotplaceunduerelianceonforwardlookingstatements,whichspeakonlyasofthedate ofthiscommunication.ExceptforanyobligationstodisclosematerialinformationundertheFederal securitieslaws,NYSEEuronextundertakesnoobligationtopubliclyupdateanyforwardlooking statementstoreflecteventsorcircumstancesafterthedateofthiscommunication. IMPORTANTINFORMATIONABOUTTHEPROPOSEDTRANSACTIONANDWHERETOFINDIT Thiscommunicationdoesnotconstituteanoffertosellorthesolicitationofanoffertobuyany securitiesorasolicitationofanyvoteorapproval.Inconnectionwiththeproposedtransaction,ICE hasfiledwiththeSECaregistrationstatementonFormS4,whichincludesajointproxy statement/prospectuswithrespecttotheproposedacquisitionofNYSEEuronext.Thefinaljointproxy statement/prospectuswillbedeliveredtothestockholdersofICEandNYSEEuronext.INVESTORSAND SECURITYHOLDERSOFBOTHICEANDNYSEEURONEXTAREURGEDTOREADTHEJOINTPROXY STATEMENT/PROSPECTUSREGARDINGTHEPROPOSEDTRANSACTIONCAREFULLYANDINITS ENTIRETY,INCLUDINGANYDOCUMENTSPREVIOUSLYFILEDWITHTHESECANDINCORPORATEDBY REFERENCEINTOTHEJOINTPROXYSTATEMENT/PROSPECTUS,ASWELLASANYAMENDMENTSOR SUPPLEMENTSTOTHOSEDOCUMENTS,BECAUSEITWILLCONTAINIMPORTANTINFORMATION REGARDINGICE,NYSEEURONEXTANDTHEPROPOSEDTRANSACTION.Investorsandsecurityholders mayobtainafreecopyofthejointproxystatement/prospectus,aswellasotherfilingscontaining informationaboutICEandNYSEEuronext,withoutcharge,attheSECswebsiteat http://www.sec.gov.Investorsmayalsoobtainthesedocuments,withoutcharge,fromICEswebsite athttp://www.theice.comandfromNYSEEuronextswebsiteathttp://www.nyx.com

PARTICIPANTSINTHEMERGERSOLICITATION ICE,NYSEEuronextandtheirrespectivedirectors,executiveofficersandothermembersof managementandemployeesmaybedeemedtobeparticipantsinthesolicitationofproxiesinrespect ofthetransactionscontemplatedbytheMergerAgreement. YoucanfindinformationaboutICEandICEsdirectorsandexecutiveofficersinICEsAnnualReporton Form10KfortheyearendedDecember31,2011,asfiledwiththeSEConFebruary8,2012,andICEs proxystatementforits2012annualmeetingofstockholders,asfiledwiththeSEConMarch30,2012. YoucanfindinformationaboutNYSEEuronextandNYSEEuronextsdirectorsandexecutiveofficersin NYSEEuronextsAnnualReportonForm10KfortheyearendedDecember31,2011,asfiledwiththe SEConFebruary29,2012,andNYSEEuronextsproxystatementforits2012annualmeetingof stockholders,filedwiththeSEConMarch26,2012. Additionalinformationabouttheinterestsofpotentialparticipantswillbeincludedinthejointproxy statement/prospectuses,whenitbecomesavailable,andtheotherrelevantdocumentsfiledbyICE andNYSEEuronextwiththeSEC.

NYSE Euronext Monthly Volume Summary

Average Daily Volume (Unaudited; contracts in thousands) Number of Trading Days - European Cash Number of Trading Days - European Derivatives Number of Trading Days - U.S. Markets European Derivatives Products of which Bclear Total Fixed Income Products Short Term Interest Rate Products Medium and Long Term Interest Rate Products 1 Total Equity Products
2

Total Volume janv-13 22 22 21 janv-12 22 22 20 70 891 12 014 40 529 37 904 2 625 28 711 19 936 8 837 11 099 8 775 12 014 10 701 8 837 1 865 1 312 1 651 51,0% 88,1% 64,3% 65,9% 42,1% 34,2% 39,7% 97,2% -6,1% 21,6% 87,9% 84,5% 94,4% 37,6% 115,8% 18,5% % Chg

Average Daily Volume % Chg vs. YTD 2013 22 22 21 4 867 1 027 3 027 2 858 170 1 751 1 266 792 474 485 1 026 898 781 117 129 89 51,0% 88,1% 64,3% 65,9% 42,1% 34,2% 39,7% 97,2% -6,1% 21,6% 87,9% 84,5% 94,4% 37,6% 115,8% 18,5% YTD 2012

Total Volume % Chg vs. YTD 2013 22 22 21 107 077 22 603 66 602 62 873 3 729 38 518 27 846 17 423 10 423 10 673 22 579 19 748 17 182 2 566 2 832 1 956 51,0% 88,1% 64,3% 65,9% 42,1% 34,2% 39,7% 97,2% -6,1% 21,6% 87,9% 84,5% 94,4% 37,6% 115,8% 18,5% YTD 2012

janv-13 22 22 21 4 867 1 027 3 027 2 858 170 1 751 1 266 792 474 485 1 026 898 781 117 129 89

janv-12 22 22 20 3 222 546 1 842 1 723 119 1 305 906 402 504 399 546 486 402 85 60 75

% Chg

51,0% 88,1% 64,3% 65,9% 42,1% 34,2% 39,7% 97,2% -6,1% 21,6% 87,9% 84,5% 94,4% 37,6% 115,8% 18,5%

107 077 22 603 66 602 62 873 3 729 38 518 27 846 17 423 10 423 10 673 22 579 19 748 17 182 2 566 2 832 1 956

Individual Equity Products Futures Options Equity Index Products of which Bclear Individual Equity Products Futures Options Equity Index Products Commodity Products U.S. Derivatives Products Equity Options
3

NYSE Euronext Options Contracts Total Consolidated Options Contracts NYSE Group Share of Total NYSE Liffe U.S. Futures and Futures Options Volume* European Cash Products (trades in thousands) Equities Exchange-Traded Funds Structured Products Bonds U.S. Cash Products (shares in millions) 5 NYSE Listed (Tape A) Issues
4

4 584 15 584 29,4%

4 171 15 668 26,6%

9,9% -0,5%

96 262 327 266 29,4%

83 425 313 363 26,6%

15,4% 4,4%

4 584 15 584 29,4%

9,9% -0,5% 2,8%

96 262 327 266 29,4%

15,4% 4,4% 2,8%

50,9 1 293 1 242 13 31 6 1 554

94,9 1 510 1 455 15 35 5 1 814

-46,4% -14,4% -14,7% -16,6% -10,2% 41,2% -14,4%

1 120 28 436 27 327 284 682 143 32 625

1 993 33 222 32 020 341 760 101 36 277

-43,8% -14,4% -14,7% -16,6% -10,2% 41,2% -10,1%

50,9 1 293 1 242 13 31 6 1 554

-46,4% -14,4% -14,7% -16,6% -10,2% 41,2% -14,4%

1 119,8 28 436 27 327 284 682 143 32 625

-43,8% -14,4% -14,7% -16,6% -10,2% 41,2% -10,1%

Handled Volume 5 Matched Volume 6 Total NYSE Listed Consolidated Volume Share of Total Consolidated Volume Handled Volume 5 Matched Volume 6 NYSE Arca, MKT and Regional (Tape B) Listed Issues Handled Volume 5 Matched Volume 6 Total NYSE Arca & MKT Listed Consolidated Volume Share of Total Consolidated Volume Handled Volume 5 Matched Volume 6 Nasdaq Listed (Tape C) Issues Handled Volume 5 Matched Volume 6 Total Nasdaq Listed Consolidated Volume Share of Total Consolidated Volume Handled Volume 5 Matched Volume 6 Exchange-Traded Products 5,7 Handled Volume 5 Matched Volume 6 Total ETF Consolidated Volume Share of Total Consolidated Volume Handled Volume 5 Matched Volume 6

1 122 1 076 3 622

1 291 1 217 4 014

-13,1% -11,6% -9,8%

23 554 22 594 76 056

25 826 24 347 80 288

-8,8% -7,2% -5,3%

1 122 1 076 3 622

-13,1% -11,6% -9,8%

23 554 22 594 76 056

-8,8% -7,2% -5,3%

31,0% 29,7%

32,2% 30,3%

-1,2% -0,6%

31,0% 29,7%

32,2% 30,3%

-1,2% -0,6%

31,0% 29,7%

-1,2% -0,6%

31,0% 29,7%

-1,2% -0,6%

217 200 951 22,9% 21,0%

272 242 1 114 24,4% 21,8%

-20,0% -17,6% -14,6% -1,5% -0,8%

4 565 4 194 19 977 22,9% 21,0%

5 433 4 850 22 272 24,4% 21,8%

-16,0% -13,5% -10,3% -1,5% -0,8%

217 200 951 22,9% 21,0%

-20,0% -17,6% -14,6% -1,5% -0,8%

4 565 4 194 19 977 22,9% 21,0%

-16,0% -13,5% -10,3% -1,5% -0,8%

215 190 1 874 11,4% 10,2%

251 214 1 818 13,8% 11,8%

-14,5% -11,0% 3,1% -2,4% -1,6%

4 506 4 000 39 357 11,4% 10,2%

5 018 4 279 36 355 13,8% 11,8%

-10,2% -6,5% 8,3% -2,4% -1,6%

215 190 1 874 11,4% 10,2%

-14,5% -11,0% 3,1% -2,4% -1,6%

4 506 4 000 39 357 11,4% 10,2%

-10,2% -6,5% 8,3% -2,4% -1,6%

207 191 920

256 228 1 074

-18,9% -16,4% -14,3%

4 355 4 001 19 314

5 116 4 556 21 470

-14,9% -12,2% -10,0%

207 191 920

-18,9% -16,4% -14,3%

4 355 4 001 19 314

-14,9% -12,2% -10,0%

22,5% 20,7%

23,8% 21,2%

-1,3% -0,5%

22,5% 20,7%

23,8% 21,2%

-1,3% -0,5%

22,5% 20,7%

-1,3% -0,5%

22,5% 20,7%

-1,3% -0,5%

Data includes currency products. all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.

2 I Includes 3 4 5

Includes trading in U.S. equity options contracts, not equity-index options. Includes all volume executed in NYSE Group crossing sessions. Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. Data included in previously identified categories. ADVs calculated with the appropriate number of NYSE Liffe U.S. trading days. Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. Data has been adjusted for duplicate trades submitted to the Consolidated Tape on 1/28/13. All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.

6 7 *